Kidney patients on higher tamsulosin dose face greater danger?
NCT ID NCT07274228
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 14,000 older adults (66+) with advanced chronic kidney disease who started taking tamsulosin. Researchers compared those on a higher dose (0.8 mg/day) to those on a lower dose (0.4 mg/day) to see if the higher dose led to more hospital visits or deaths within 90 days. The goal was to understand the safety of this common prostate medication in this vulnerable group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Plastics in dialysis: could they add toxins to Children's blood?
- Can a newer heart failure drug protect kidneys better than an older one?
- A urine test strip that could transform kidney diet care?
- Can a Home-Based program help kidney patients get stronger before transplant?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Hidden patterns: how three chronic diseases often travel together